Gordon Gillerman

Gordon Gillerman, Director, Standards Coordination Office at the National Institute of Standards and Technology (NIST) and Department of Commerce Standards Executive, leads NIST’s work in standards coordination and the National Voluntary Laboratory Accreditation Program. Gordon supports extensive standards development and advises federal agencies and other stakeholders on standards and conformity assessment policy. The Standards Coordination Office is the NIST standardization focal point for federal government, administers the NIST Standards Curricula Development Cooperative Agreement Program, operates the U.S. Inquiry Point for the World Trade Organization’s Technical Barriers to Trade Agreement, is the U.S. Designating Authority for Telecom Mutual Recognition Agreements, and is a key information source for US industry on standards related market access issues.

Gordon has extensive standards experience across a wide range of critical issues including homeland security, safety, health, and protection of the environment. Gordon is an expert on conformity assessment systems design, an advisor to the U.S. Trade Representative on technical barriers to trade and related trade agreements, and has collaborated across the standards community to develop standards based solutions for national priorities throughout his career. Gordon provided direct support in the drafting and negotiation of the Technical Barriers to Trade chapter of the USMCA.

Prior experience includes leading government affairs for the largest U.S. product safety certification and standards development organization, Underwriters Laboratories (UL) in Washington, DC, and Staff Engineer for the medical device and information technology sectors at UL’s Northbrook, IL headquarters.

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More

U.S. Universities: Engines of Economic Growth

By Sujai Shivakumar, Charles Wessner, Chris Borges, and Shruti Sharma Universities are among the United States’ most enduring sources of competitive advantage and a key pillar of the nation’s innovation system. Home to more than 35 of the world’s top 100 research universities, the United States owes many of its most
Read More

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More